ConductScience.org, home

Paper37720348

Nuclear epidermal growth factor receptor as a therapeutic target.

Atwell B and 2 others. Explor Target Antitumor Ther, 2023. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Nuclear epidermal growth factor receptor as a therapeutic target. Papers, record 37720348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37720348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nuclear epidermal growth factor receptor as a therapeutic target.
PubMed
Journal
Explor Target Antitumor Ther
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2023-09-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Atwell BBenjaminhttps://orcid.org/0000-0003-2160-1561
2Chalasani PPavanihttps://orcid.org/0000-0002-7953-2979
3Schroeder JJoycehttps://orcid.org/0000-0003-1277-5172

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135295841Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers.Front Mol Biosci2022https://conductscience.org/library/papers/35295841PubMed
221266349EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.Cancer Res2011https://conductscience.org/library/papers/21266349PubMed
321520037A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.Int J Cancer2011https://conductscience.org/library/papers/21520037PubMed
418723476Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.Mol Cancer Ther2008https://conductscience.org/library/papers/18723476PubMed
532053675Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.PLoS One2020https://conductscience.org/library/papers/32053675PubMed
68638121Enhanced degradation of EGF receptors by a sorting nexin, SNX1.Science1996https://conductscience.org/library/papers/8638121PubMed
721487020Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.J Biol Chem2011https://conductscience.org/library/papers/21487020PubMed
822520625Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family.Cell Biosci2012https://conductscience.org/library/papers/22520625PubMed
931747009INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.Neuro Oncol2020https://conductscience.org/library/papers/31747009PubMed
1032793488Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics.Front Oncol2020https://conductscience.org/library/papers/32793488PubMed
111980216Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation.Biochemistry1990https://conductscience.org/library/papers/1980216PubMed
1231401198Anti-EGFR antibody conjugated thiol chitosan-layered gold nanoshells for dual-modal imaging-guided cancer combination therapy.J Control Release2019https://conductscience.org/library/papers/31401198PubMed
1329445288Prognostic significance of epidermal growth factor receptor expression in glioma patients.Onco Targets Ther2018https://conductscience.org/library/papers/29445288PubMed
1425189483Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.Clin Cancer Res2014https://conductscience.org/library/papers/25189483PubMed
1519887552MUC1 oncoprotein is a druggable target in human prostate cancer cells.Mol Cancer Ther2009https://conductscience.org/library/papers/19887552PubMed
1622665533TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.J Clin Oncol2012https://conductscience.org/library/papers/22665533PubMed
1715665312Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.Cancer Res2005https://conductscience.org/library/papers/15665312PubMed
1833758141Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma.Appl Immunohistochem Mol Morphol2021https://conductscience.org/library/papers/33758141PubMed
1919058255Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer.Mol Carcinog2009https://conductscience.org/library/papers/19058255PubMed
2035427766EGFR signaling pathway as therapeutic target in human cancers.Semin Cancer Biol2022https://conductscience.org/library/papers/35427766PubMed

See all 87 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42040768From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer.Cancer Drug Resist2026https://conductscience.org/library/papers/42040768PubMed
41871146The differential roles of Giardia duodenalis-secreted tenascins in inducing intestinal epithelial cell apoptosis and the attributed EGFR-STAT3 axis regulation.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41871146PubMed
41420294Tissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography-Tandem Mass Spectrometry.Vet Comp Oncol2026https://conductscience.org/library/papers/41420294PubMed
41228309SH003 as a Redox-Immune Modulating Phytomedicine: A Ferroptosis Induction, Exosomal Crosstalk, and Translational Oncology Perspective.Cancers (Basel)2025https://conductscience.org/library/papers/41228309PubMed
40943631Real-Time Kinetics of Internalization of Anti-EGFR DNA Aptamers and Aptamer Constructs into Cells Derived from Glioblastoma Patients as Indicated by Doxorubicin.Int J Mol Sci2025https://conductscience.org/library/papers/40943631PubMed
39940647Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (Potamotrygon spp.) as a Drug Carrier in Glioblastoma Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/39940647PubMed
39456666Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing.Int J Mol Sci2024https://conductscience.org/library/papers/39456666PubMed

Download CSV of cited by

Genes38

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
AFM173PubTator's text mininghttps://conductscience.org/library/genes/173NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ANXA7310PubTator's text mininghttps://conductscience.org/library/genes/310NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
DHX91660PubTator's text mininghttps://conductscience.org/library/genes/1660NCBI Gene
E2F11869PubTator's text mininghttps://conductscience.org/library/genes/1869NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
ERBB42066PubTator's text mininghttps://conductscience.org/library/genes/2066NCBI Gene
F32152PubTator's text mininghttps://conductscience.org/library/genes/2152NCBI Gene
KMT5A387893PubTator's text mininghttps://conductscience.org/library/genes/387893NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
MUC14582PubTator's text mininghttps://conductscience.org/library/genes/4582NCBI Gene

See all 38 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37720348

GET https://conductscience.org/api/papers/v1/37720348/references?page=2